ExpiresFebruary 13, 2022
Louisiana Medical Mutual Insurance Company (LAMMICO)
It is estimated that only half of those infected with Hepatitis C Virus in the US are diagnosed and perhaps a third receive treatment. The arrival of new direct-acting antiviral medications with high cure rates has spurred the creation of new guidelines for expanded HCV screening. Primary care physicians are in the best position to carry out screening and testing but may lack experience. This activity will assist physicians in becoming familiar with the new screening guidelines, a testing algorithm, and recommendations regarding referral for treatment.
Pre and posttest evaluation at the end of the course. Post activity survey 3 months asking for what practice changes were made.
ABMS Member Board Approvals by Type
ABMS MOC Part II CME Activity
NOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
To elicit from a patient the HCV exposure history and risk factors that would indicate the patient should be tested for HCV, according to current guidelines.
To explain the HCV testing algorithm to a patient for whom testing is indicated.
To implement the screening guidelines and testing algorithm in your practice.
To identify the advantages of referring the HCV-positive patient for treatment by a specialist.
Medical Knowledge, Rapid HCV Screening Test, Hepatitis C, Hepatitis C risk Factors, HCV and HIV, HCV Treatment, HCV Referral
Interpersonal & Communication Skills, Medical Knowledge, Patient Care & Procedural Skills, Practice-based Learning & Improvement, Professionalism
CME Credit Type
AMA PRA Category 1 Credit
Outpatient, Rural, Urban
National Quality Strategies and/or Quadruple Aim Care Processes
Patient Safety/Medical Errors, Evidence Based Practice, Health Education